$1.160
-0.010 (-0.85%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による MGX の予測・予想
Alphio's MGX stock price prediction model matches the current Metagenomi Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.16 (-0.23%). The 1-week path is $1.22 (+4.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Metagenomi Therapeutics Inc 株は買うべき？
Metagenomi Inc is not a good buy right now due to significant financial losses and negative performance trends. The current price is $1.19, with a year-to-date change of -28.74% and a 1-year change of -34.62%. Additionally, the RSI is at 35.391, indicating potential oversold conditions but also reflecting weak momentum. The main risk is the ongoing net losses, with the latest reported net income at -$27,482,000 for Q2 2026, which raises concerns about the company's financial stability.
MGX の株価は Wednesday に $1.16 で引け、その前に下落 -0.85%
Metagenomi Therapeutics Inc (MGX) last closed at $1.16, losing -0.85%. These facts feed the 1-day and 1-week MGX price prediction above.
予想の要因
Metagenomi Therapeutics Inc（MGX）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが MGX に最も近い銘柄を、類似度順に表示します。
MGX の季節性分析
Historically the probability of a positive September return for MGX is 0.00%. March offers the highest probability of a positive month at 31.75%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。